324 related articles for article (PubMed ID: 29159795)
1. Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life.
Miaskowski C; Mastick J; Paul SM; Abrams G; Cheung S; Sabes JH; Kober KM; Schumacher M; Conley YP; Topp K; Smoot B; Mausisa G; Mazor M; Wallhagen M; Levine JD
J Cancer Surviv; 2018 Apr; 12(2):234-245. PubMed ID: 29159795
[TBL] [Abstract][Full Text] [Related]
2. Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors.
Miaskowski C; Paul SM; Mastick J; Abrams G; Topp K; Smoot B; Kober KM; Chesney M; Mazor M; Mausisa G; Schumacher M; Conley YP; Sabes JH; Cheung S; Wallhagen M; Levine JD
J Pain Symptom Manage; 2018 Jul; 56(1):88-97. PubMed ID: 29524582
[TBL] [Abstract][Full Text] [Related]
3. Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.
Miaskowski C; Paul SM; Mastick J; Schumacher M; Conley YP; Smoot B; Abrams G; Kober KM; Cheung S; Henderson-Sabes J; Chesney M; Mazor M; Wallhagen M; Levine JD
Eur J Oncol Nurs; 2018 Feb; 32():1-11. PubMed ID: 29353626
[TBL] [Abstract][Full Text] [Related]
4. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
[TBL] [Abstract][Full Text] [Related]
5. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
Brydøy M; Oldenburg J; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Hauge ER; Dahl O; Fosså SD
J Natl Cancer Inst; 2009 Dec; 101(24):1682-95. PubMed ID: 19940282
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.
Kober KM; Mazor M; Abrams G; Olshen A; Conley YP; Hammer M; Schumacher M; Chesney M; Smoot B; Mastick J; Paul SM; Levine JD; Miaskowski C
J Pain Symptom Manage; 2018 Dec; 56(6):908-919.e3. PubMed ID: 30172061
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.
Zhang X; Trendowski MR; Wilkinson E; Shahbazi M; Dinh PC; Shuey MM; ; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Huddart R; Martin NE; Sanchez VA; Frisina RD; Einhorn LH; Cox NJ; Travis LB; Dolan ME
Cancer Med; 2022 Jul; 11(14):2801-2816. PubMed ID: 35322580
[TBL] [Abstract][Full Text] [Related]
9. Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review.
Pearson SE; Taylor J; Patel P; Baguley DM
Int J Audiol; 2019 Nov; 58(11):685-695. PubMed ID: 31545660
[No Abstract] [Full Text] [Related]
10. Chemotherapy-Induced Neuropathy in Cancer Survivors.
Miaskowski C; Mastick J; Paul SM; Topp K; Smoot B; Abrams G; Chen LM; Kober KM; Conley YP; Chesney M; Bolla K; Mausisa G; Mazor M; Wong M; Schumacher M; Levine JD
J Pain Symptom Manage; 2017 Aug; 54(2):204-218.e2. PubMed ID: 28063866
[TBL] [Abstract][Full Text] [Related]
11. Cancer survivors and neurotoxic chemotherapy: hearing loss and tinnitus.
Cheung S; Henderson-Sabes J; Mastick J; Abrams G; Snowberg K; Alfaro E; Quinn M; Paul S; Cooper B; Wallhagen M; Conley Y; Levine J; Miaskowski C
BMJ Support Palliat Care; 2023 Sep; 13(3):345-353. PubMed ID: 35896321
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
Sanchez VA; Dinh PC; Rooker J; Monahan PO; Althouse SK; Fung C; Sesso HD; Einhorn LH; Dolan ME; Frisina RD; Travis LB
J Cancer Surviv; 2023 Feb; 17(1):27-39. PubMed ID: 36637632
[TBL] [Abstract][Full Text] [Related]
13. The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study.
Pearson SE; Caimino C; Shabbir M; Baguley DM
J Cancer Surviv; 2022 Oct; 16(5):976-987. PubMed ID: 34398361
[TBL] [Abstract][Full Text] [Related]
14. Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study.
ArdeshirRouhaniFard S; Dinh PC; Monahan PO; Fossa SD; Huddart R; Fung C; Song Y; Feldman DR; Hamilton RJ; Vaughn DJ; Martin NE; Kollmannsberger C; Einhorn L; Kroenke K; Travis LB
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1129-1138. PubMed ID: 33849970
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors.
Trendowski MR; Wheeler HE; El-Charif O; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Einhorn LH; Travis LB; Dolan ME
Clin Cancer Res; 2020 Dec; 26(24):6550-6558. PubMed ID: 32998964
[TBL] [Abstract][Full Text] [Related]
16. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
Knoerl R; Weller E; Halpenny B; Berry D
BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
[TBL] [Abstract][Full Text] [Related]
17. Associations among hearing loss, multiple co-occurring symptoms, and quality of life outcomes in cancer survivors.
Miaskowski C; Mastick J; Paul S; Wallhagen M; Abrams G; Levine JD
J Cancer Surviv; 2023 Feb; 17(1):59-68. PubMed ID: 36454519
[TBL] [Abstract][Full Text] [Related]
18. Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors.
Galantino ML; Tiger R; Brooks J; Jang S; Wilson K
Integr Cancer Ther; 2019; 18():1534735419850627. PubMed ID: 31131640
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment.
Zanville NR; Nudelman KN; Smith DJ; Von Ah D; McDonald BC; Champion VL; Saykin AJ
Support Care Cancer; 2016 Nov; 24(11):4779-89. PubMed ID: 27470258
[TBL] [Abstract][Full Text] [Related]
20. Falls in persons with chemotherapy-induced peripheral neuropathy.
Tofthagen C; Overcash J; Kip K
Support Care Cancer; 2012 Mar; 20(3):583-9. PubMed ID: 21380613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
